Respiratory syncytial virus vaccine – May 2024

• Brand name:
  • Abrysvo®
• Pharmaceutical Company:
  • PFIZER AUSTRALIA PTY LTD
• Condition/Indication: Lower respiratory tract illness
• Meeting Date: May 2024
• Public Summary Document (PSD) March 2024 May 2024 PBAC Meetings - (PDF 981KB)
• Public Summary Document (PSD) March 2024 May 2024 PBAC Meetings - (Word 303KB)

Related Public Summary Documents

• Respiratory syncytial virus vaccine – March 2024